Inventor profile of:

Cameron J. Turtle

City:

Seattle, Washington

Country:

United States

Published Applications:

14

Last publication date:

2025-06-19

Top Assignees for applications by Cameron J. Turtle

The entities that hold a legal rights for patent applications filed by inventor Turtle Cameron J.:

Recent patent applications by Turtle Cameron J.

Cameron J. Turtle from Seattle, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-06-19
US20250197471A1
Chemistry; metallurgy

METHODS FOR THE TREATMENT OF B CELL MALIGNANCIES USING ADOPTIVE CELL THERAPY

#2 | 2024-03-28
US20240103012A1
Physics

METHODS AND COMPOSITIONS RELATED TO TOXICITY ASSOCIATED WITH CELL THERAPY

#3 | 2023-07-13
US20230220103A1
Chemistry; metallurgy

CHIMERIC ANTIGEN RECEPTORS TARGETING CD33

#4 | 2023-07-13
US20230218669A1
Human necessities

AUGMENTING ANTIGEN-NEGATIVE CELL DEATH IN ANTIGEN-TARGETED IMMUNOTHERAPIES

#5 | 2023-05-25
US20230158164A1
Human necessities

METHOD FOR ENHANCING CELLULAR IMMUNOTHERAPY

#6 | 2023-05-18
US20230151094A1
Chemistry; metallurgy

CHIMERIC ANTIGEN RECEPTORS TARGETING CD33

#7 | 2023-01-05
US20230003733A1
Physics

BIOMARKERS AND USES THEREOF FOR SELECTING IMMUNOTHERAPY INTERVENTION

#8 | 2021-07-22
US20210223248A1
Physics

BIOMARKERS, USES THEREOF FOR SELECTING IMMUNOTHERAPY INTERVENTION, AND IMMUNOTHERAPY METHODS

#9 | 2020-01-16
US20200016199A1
Human necessities

METHODS FOR THE TREATMENT OF B CELL MALIGNANCIES USING ADOPTIVE CELL THERAPY

#10 | 2019-11-28
US20190361026A1
Physics

Biomarkers and uses thereof for selecting immunotherapy intervention

#11 | 2019-09-12
US20190277858A1
Physics

Methods and compositions related to toxicity associated with cell therapy

#12 | 2018-08-30
US20180243386A1
Human necessities

Identification of CD8T cells that are CD161and/or IL18R(α)and have rapid drug efflux capacity

#13 | 2016-02-18
US20160045580A1
Human necessities

Identification of CD8T cells that are CD161and/or IL18Rαand have rapid drug efflux capacity

#14 | 2011-03-10
US20110059012A1
Human necessities

Identifcation of CD8 T cells that are CD161and/or IL18Rαand have rapid drug efflux capacity

InventorID:

1443854 ⎘